Centivax
centivax.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$82M
2 rounds on record
Latest round
$37M
Venture round · Mar 2026 · 6 mo ago
Team
22
US Form 5500 (plan participants) · Dec 2025 · +29% in a year
Backers
2
Amplifypartners, Future Ventures
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 25
Raised a round Venture round $37M
2025
Team of 22 was 17 · US Form 5500 (plan participants)
Jul 8, 2025
Raised a round Series A $45M · led by Steve Jurvetson's Future Ventures
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2026 | $37M | — | axios.com |
| Series A | Jul 2025 | $45M | Steve Jurvetson's Future Ventures lead, NFX, BOLD Capital, Base4, Kendall Capital Partners, Amplify Bio | hitconsultant.net |
Backed byfrom the funds' portfolios and accelerator catalogs
Amplifypartners 
Future Ventures News
Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readiness
/PRNewswire/ -- Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly...
Read more
Report
Centivax Closes $37 Million Financing to Accelerate Phase 2 Clinical Development of Universal Flu and Advance Follow-On Portfolio to Clinical Readiness
Read more
Report
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform
Read more
Report
Centivax Initiates Phase 1 First-in-Human Clinical Trial of Universal Flu Vaccine
/PRNewswire/ -- Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly...
Read more
Report
"Find a Way to Break Reality": How Centivax Brought a Universal Flu Vaccine to Clinic
NFX-backed Centivax is bringing their universal flu vaccine into Phase I clinical trials. We sat down with founder Jake Glanville to discuss the strategy that led them there.
Read more
Report
Pro access
Upgrade to see all 40 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
Regional office
50-200 est. staff
1 Tower Place, Suite 800 South San Francisco, CA, 94080 United States